Data Foundry

Drug recalls 2014

RANOLAZINE ER Tablet — Class II drug recall D-667-2014

Terminated recall by Aidapak Services, LLC, reported 2014-01-22, distributed in AZ, CA, OR, WA. Labeling:Label Mixup; RANOLAZINE ER Tablet, 500 mg may be potentially mislabeled as MELATONIN, Tablet, 3 mg, N

Recall numberD-667-2014
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAidapak Services, LLC, Vancouver, WA, United States
Recall initiated2013-07-02
Classified2014-01-16
Reported by FDA2014-01-22
Terminated2014-02-07
DistributedAZ, CA, OR, WA
Quantity840 tablets
Reason classeslabeling
Expiration dates2014-05-02, 2014-05-13, 2014-05-22, 2014-05-29, 2014-06-07, 2014-06-21, 2014-06-25, 2014-06-26

Product

RANOLAZINE ER Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 61958100301

Reason for recall

Labeling:Label Mixup; RANOLAZINE ER Tablet, 500 mg may be potentially mislabeled as MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: AD25452_16, EXP: 5/3/2014; DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree: AD70585_16, EXP: 5/29/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W002852, EXP: 6/7/2014; VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree:

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-667-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.